IN THIS ISSUE
Managing Editor’s Memo
Frank Diamond
Legislation & Regulation
Richard Mark Kirkner
Contractor has challenges to overcome in turning a dead parrot into a phoenix.
Value-Based Tools
Michael D. Dalzell
Three quarters of the original ACOs that remain in the MSSP are still in Track 1. The Trump administration is tired of waiting for them to take on two-sided risk.
Medication Management
Thomas Reinke
Next month, the Sanofi and Regeneron product is expected to become the fourth monoclonal antibody approved as a treatment for severe asthma.
Viewpoint
François de Brantes
Public opposition would be unseemly, so insurers and hospitals work behind the scenes against price transparency.
Viewpoint
Laurie Golemi Norman, MSN, APRN
For organizations with a good strategy to reduce care variation, a hospital efficiency improvement program can provide the jolt of incentive that generates real improvement.
Viewpoint
Maggie Alston
Bruce Pyenson
Pharma is used to risk, but adoption of alternative payment models would mean learning to navigate shared risk with payers.
News & Commentary